Ronald Blue Trust, Inc. Legend Biotech Corp Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 362 shares of LEGN stock, worth $11,377. This represents 0.0% of its overall portfolio holdings.
Number of Shares
362
Previous 814
55.53%
Holding current value
$11,377
Previous $36,000
52.78%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$351 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$236 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$209 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$180 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$158 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.26B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...